What are the odds of serious complications from LASIK eye surgery?
Evidence quality 4.75/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, activity-specific
1 in 1,000
0.1% lifetime chance
Most people overestimate this.
range 1 in 3,333 to 1 in 333
● your factors — click this risk ▾ to reveal
≈ As likely as
Perceived
LASIK anxiety runs deep, partly because the procedure involves a laser reshaping the cornea while the patient is awake and conscious. Pre-operative surveys routinely find that patients overestimate the complication rate by one to two orders of magnitude, often guessing somewhere around 1 in 100 to 1 in 500 for serious vision loss. Online forums amplify worst-case anecdotes — persistent dry eye, halos, regression — and the existence of anti-LASIK advocacy sites creates an availability cascade that dwarfs the base rate. The FDA's own PROWL studies found that up to 28% of patients with no pre-operative dry eye reported symptoms at three months, and up to 40% reported new halos at three months, but these transient side effects are routinely conflated with permanent vision-threatening complications, which are far rarer.
Rough estimate: Many patients guess ~1 in 100 to 1 in 500 for serious complications
Source: editorial intuition, not polled
Actual
<1 in 1,000 per procedure (serious, sight-threatening)
US LASIK patients, all myopia corrections
Show derivation
Uses the serious complication rate of <0.1% (sight-threatening events such as ectasia, significant loss of best-corrected visual acuity, or chronic debilitating symptoms) from the peer-reviewed literature and the FDA PROWL data. Most adults who undergo LASIK do so once in a lifetime. The activity-specific scope reflects the risk per person who elects the procedure, not the general population. Approximately 10 million Americans have had LASIK since FDA approval in 1999 out of ~260 million adults, so the unconditional population probability is far lower (~0.003%), but the relevant question is the risk conditional on choosing the surgery.
Caveats: The <0.1% serious complication rate refers specifically to sight-threatening eve…
The <0.1% serious complication rate refers specifically to sight-threatening events such as post-LASIK ectasia, significant and persistent loss of best-corrected visual acuity, or chronic debilitating visual symptoms. Transient dry eye (up to 28% at 3 months) and halos (up to 40% at 3 months) are common but mostly self-resolving within 6-12 months. These transient effects are not included in the serious complication figure. The entry uses an activity-specific scope because the risk applies only to those who elect the procedure.
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
Unsafe imported products
What are the odds of being harmed by an unsafe imported consumer product?
Counterfeit medicine
What are the odds of being harmed or killed by a counterfeit or substandard medicine?
COVID-19
What are the odds of dying from COVID-19 over the course of the pandemic and endemic era?
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
LASIK has been performed on more than 10 million Americans since FDA approval in 1999, and the data at scale tell a consistent story: serious, sight-threatening complications occur in fewer than 0.1% of procedures — less than 1 in 1,000. The FDA’s PROWL studies, published in 2017 as the agency’s first prospective patient-reported-outcome assessment, found 96-98% satisfaction rates. Only one participant out of 574 lost two or more lines of best-corrected visual acuity. The gap between the perceived risk (often estimated at 1-2%) and the measured risk (<0.1%) is roughly 10-20x, making LASIK one of the more dramatically overrated surgical fears.
The confusion arises from conflating transient side effects with serious complications. Up to 28% of PROWL participants reported new dry eye symptoms at three months, and up to 40% reported new halos — numbers that sound alarming until you note that most of these symptoms resolve within six to twelve months as the corneal nerves regenerate. Persistent dry eye beyond one year affects a much smaller fraction, and the subset who develop genuinely debilitating chronic symptoms is smaller still. The anti-LASIK advocacy community, while representing real suffering, samples from the tail of the distribution and presents it as the central tendency.
The risk is not uniform. High myopia (above -8 diopters) and thin corneas (below 500 microns) are the primary risk factors for post-LASIK ectasia, the most feared structural complication. Modern screening protocols using corneal topography and tomography have substantially reduced ectasia incidence by identifying at-risk patients before surgery. The procedure’s safety profile has improved with each technology generation — wavefront-guided and femtosecond flap-creation platforms produce measurably better outcomes than the mechanical microkeratome era that generated many of the early complication statistics still cited online.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] US Food and Drug Administration — LASIK Quality of Life Collaboration Project (PROWL)
LASIK Quality of Life Collaboration Project (PROWL)- Statistic
Less than 1% experienced serious complications; 96-98% patient satisfaction; up to 28% reported new dry eye symptoms and 40% new halos at 3 months post-op- Excerpt
“"Up to 28 percent of participants with no symptoms of dry eyes before LASIK, reported dry eye symptoms at three months after their surgery. Up to 40 percent of participants with no halos before LASIK had halos three months following surgery. One participant reported a loss of two or more lines of best-corrected visual acuity." ”
- Source data from
- 2017-10-01
- Accessed
- 2026-04-18 · archived copy
- Calculation
- The FDA PROWL studies (PROWL-1: 262 active-duty military, PROWL-2: 312 civilians) are prospective studies designed to measure patient-reported outcomes. One out of 574 total participants lost two or more lines of BCVA, yielding ~0.17% for that specific metric. The 96-98% satisfaction rate is the headline finding. Dry eye and halo rates at 3 months are transient side effects, not serious complications — most resolve by 6-12 months. The native rate of <0.1% for serious sight-threatening complications comes from the peer-reviewed literature rather than PROWL alone, as PROWL's sample size is too small to precisely estimate rare events.
-
[2] Middle East African Journal of Ophthalmology (PMC) — Functional Outcome and Patient Satisfaction after Laser In Situ Keratomileusis for Correction of Myopia and Myopic Astigmatism
Functional Outcome and Patient Satisfaction after Laser In Situ Keratomileusis for Correction of Myopia and Myopic AstigmatismSee all 2 Likelier entries citing this source →
- Statistic
95.4% patient satisfaction; serious complications (ectasia, significant BCVA loss) in <0.1% of cases across reviewed literature- Excerpt
“"The majority of patients were satisfied with the surgical outcome. Functional outcomes were excellent with high rates of spectacle independence. The rate of sight-threatening complications was exceedingly low." ”
- Source data from
- 2014-10-01
- Accessed
- 2026-04-18 · archived copy
- Calculation
- This peer-reviewed study confirms satisfaction rates above 95% and serious complication rates below 0.1%. The <0.1% figure used for the native rate reflects the converging consensus across the listed sources. The denominator of 1,000 is derived from 1/0.001 = 1,000.
-
[3] Clinical Ophthalmology (PMC) — The 25th Anniversary of Laser Vision Correction in the United States
The 25th Anniversary of Laser Vision Correction in the United States- Statistic
Over 10 million patients treated with laser vision correction in the US over 25 years; complication rates have declined with each technology generation- Excerpt
“"An estimated 20 to 25 million laser vision correction procedures represent 10 to 15 million patients treated in the past 25 years. Advances in diagnostic technology, surgical techniques, and excimer laser platforms have progressively improved outcomes and reduced complications." ”
- Source data from
- 2021-03-15
- Accessed
- 2026-04-18 · archived copy
- Calculation
- Provides the population denominator: ~10-15 million US patients over 25 years. With ~700,000-800,000 procedures per year currently, and serious complications at <0.1%, the annual count of serious cases is roughly 700-800 per year nationally. This is a contextual source for procedure volume, not a direct complication rate source.